IIP
AMGN icon

Intermede Investment Partners’s Amgen AMGN Stock Holding History

Intermede Investment Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-246,290
Closed -$42.8M – 26
2017
Q4 		$42.8M Buy
246,290
+11,253
+5% +$1.99M 3.64% 17
2017
Q3 		$43.8M Buy
235,037
+1,881
+0.8% +$333K 4.01% 13
2017
Q2 		$40.2M Buy
233,156
+340
+0.1% +$55.3K 3.88% 13
2017
Q1 		$38.2M Buy
232,816
+16,945
+8% +$2.82M 3.99% 11
2016
Q4 		$31.6M Buy
215,871
+66,970
+45% +$10.1M 3.7% 15
2016
Q3 		$24.8M Buy
148,901
+1,842
+1% +$311K 2.75% 21
2016
Q2 		$22.4M Sell
147,059
-52,726
-26% -$8.2M 2.59% 19
2016
Q1 		$30M Buy
199,785
+57,465
+40% +$8.54M 3.61% 13
2015
Q4 		$23.1M Buy
+142,320
New +$22.4M 3.91% 12

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Intermede Investment Partners's AMGN Position: Q1 2018 in Review

Intermede Investment Partners sold out of Amgen (AMGN) in Q1 2018, closing a stake of 246,290 shares — an estimated $42.8M sold.

Intermede Investment Partners first reported a position in AMGN in Q4 2015 and held it in 9 quarters. The position peaked at $43.8M in Q3 2017. 1,749 funds tracked by Wall St. Rank hold AMGN as of Q1 2018.

  • Intermede Investment Partners reported no remaining Amgen position as of Q1 2018 after selling out during the quarter.
  • Intermede Investment Partners sold 246,290 Amgen shares in Q1 2018, an estimated $42.8M.
  • Intermede Investment Partners first reported a position in Amgen in Q4 2015 and held it in 9 quarters.
  • Intermede Investment Partners's Amgen position peaked at $43.8M in Q3 2017.
  • 1,749 funds tracked by Wall St. Rank held Amgen as of Q1 2018.

Based on Intermede Investment Partners's 13F filing for Q1 2018, filed 1 May 2018.